Brief: Pharma Mar's Partner Merck Submits Application For Lung Cancer Drug Zepzelca In Japan
Tue 07:11
BRIEF-Pharma Mar's Partner Merck Submits Application For Lung Cancer Drug Zepzelca In Japan June 23 (Reuters) - Pharma Mar SA PHMR.MC:
MERCK SUBMITS ZEPZELCA REGISTRATION DOSSIER TO JAPAN MHLW (MINISTRY OF HEALTH, LABOUR AND WELFARE) FOR FIRST-LINE MAINTENANCE IN SCLC
ZEPZELCA NDA RECEIVES PRIORITY REVIEW DESIGNATION IN JAPAN
Source text
Further company coverage: PHMR.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 567 69 66 00;))
Recent news on Merck KGaA
See all newsBrief: Merck Collaborates With Versant Ventures To Launch Saturnus Bio
Brief: Merck KGaA, Darmstadt, Germany, Collaborates With Versant Ventures To Launch Saturnus Bio
Brief: Pharma Mar's Partner Merck Submits Application For Lung Cancer Drug Zepzelca In Japan
Europe Research Roundup: ASML Holding, Douglas, Richemont
European shares lifted by miners and tech; Mideast in focus (updated)